SR One
Biotechnology venture capital firm investing in and building life science companies
About This Fund
Biotechnology venture capital firm investing in and building life science companies. It focuses on companies with strong fundamentals, clear development pathways, and novel approaches to disease treatment. The firm provides strategic partnership, leveraging its transatlantic presence to offer geographic reach and regional expertise, supporting portfolio companies' growth and development. This support includes business guidance and access to opportunities across various regions.
Investment Focus
What They Look For
strong fundamentals, clearly defined development pathway, novel science addressing unmet medical needs; US/UK focus; innovative biotech companies
Preparing to pitch SR One?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →